Russian President Vladimir Putin’s spokesman confirmed on Wednesday he had received an email in January last year from an adviser to Donald Trump about a Moscow real estate project, but said he had neither replied nor discussed it with Putin.
The Washington Post reported this week that Michael Cohen, one of Trump’s closest business advisers, had emailed Dmitry Peskov, Putin’s spokesman, seeking his help in advancing a stalled Trump Tower development project in Moscow.
Trump was running to become president at the time.
Peskov, answering questions about the matter on a conference call with reporters on Wednesday, said he had seen the email among many others he said he received every day, but had not responded to it because the request was not the kind of thing he dealt with in his job as Kremlin spokesman.
“I can confirm that among the mass of e-mails there was an e-mail from Mr. Michael Cohen. This really happened,” said Peskov.
He said Cohen had written about “a certain Russian company and certain people” who wanted to build a skyscraper in Moscow and wanted his help in making the stalled project a reality.
But Peskov said the request was off topic and that responding to it fell outside his job description.
“Because we do not react to such (questions about) business themes, and this is not our job, we left this matter without a response,” said Peskov.
He said the Kremlin had not received any other similar requests on the subject and that he had not raised the subject of Cohen’s original email with Putin.
“We cannot discuss the hundreds and thousands of various requests from different countries we get with President Putin,” said Peskov.
(Reporting by Dmitry Solovyov and Denis Pinchuk; Writing by Andrew Osborn; Editing by Christian Lowe)
Inside Purdue Pharma’s media playbook: How it planted the opioid ‘anti-story’
OxyContin’s makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage.
In 2004, Purdue Pharma was facing a threat to sales of its blockbuster opioid painkiller OxyContin, which were approaching $2 billion a year. With abuse of the drug on the rise, prosecutors were bringing criminal charges against some doctors for prescribing massive amounts of OxyContin.
MSNBC’s Morning Joe explains how Republicans botched Trump’s impeachment defense from Day One
MSNBC's Joe Scarborough said the polling after the first week of public impeachment hearings offered bad news to President Donald Trump.
About 58 percent of Americans are following the hearings very closely or somewhat closely, and 60 percent of those people believe Trump should be impeached and removed from office, according to a new ABC News/Ipsos poll.
Nearly one in three Americans have already made up their minds on impeachment, but about 30 percent say they could be swayed by new revelations about Trump's scheme to pressure Ukraine into announcing an investigation of Joe Biden.
Trump rails against another woman impeachment witness
“Tell Jennifer Williams, whoever that is, to read BOTH transcripts of the presidential calls, & see the just released ststement [sic] from Ukraine,” Trump tweeted. “Then she should meet with the other Never Trumpers, who I don’t know & mostly never even heard of, & work out a better presidential attack!”